0000899243-16-013516.txt : 20160217 0000899243-16-013516.hdr.sgml : 20160217 20160217161042 ACCESSION NUMBER: 0000899243-16-013516 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160212 FILED AS OF DATE: 20160217 DATE AS OF CHANGE: 20160217 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aegerion Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001338042 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 202960116 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE MAIN STREET STREET 2: SUITE 800 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: (617) 500-7867 MAIL ADDRESS: STREET 1: ONE MAIN STREET STREET 2: SUITE 800 CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Aegerion Pharmaceuticals Inc DATE OF NAME CHANGE: 20050906 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PERRY GREGORY D CENTRAL INDEX KEY: 0001236371 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34921 FILM NUMBER: 161433374 MAIL ADDRESS: STREET 1: C/O IMMUNOGEN, INC. STREET 2: 830 WINTER ST. CITY: WALTHAM STATE: MA ZIP: 02451 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-02-12 0 0001338042 Aegerion Pharmaceuticals, Inc. AEGR 0001236371 PERRY GREGORY D C/O AEGERION PHARMACEUTICALS, INC. ONE MAIN STREET, SUITE 800 CAMBRIDGE MA 02142 0 1 0 0 See Remarks Stock Option (right to buy) 5.71 2016-02-12 4 A 0 200000 0.00 A 2026-02-12 Common Stock 200000 200000 D The stock option award has an exercise price equal to the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant. The shares of common stock underlying this stock option award will vest in four equal installments as follows: 25% on February 12, 2016, 25% on December 31, 2016, 25% on December 31, 2017, and 25% on December 31, 2018, subject to the Reporting Person's continued employment with the Issuer. Chief Financial and Administration Officer /s/ Benjamin Harshbarger, attorney-in-fact 2016-02-17